Nevro Total Liabilities 2013-2024 | NVRO
Nevro total liabilities from 2013 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
| Nevro Annual Total Liabilities (Millions of US $) |
|
|---|---|
| 2023 | $343 |
| 2022 | $279 |
| 2021 | $271 |
| 2020 | $401 |
| 2019 | $253 |
| 2018 | $218 |
| 2017 | $205 |
| 2016 | $182 |
| 2015 | $57 |
| 2014 | $30 |
| 2013 | $8 |
| 2012 | $5 |
| Nevro Quarterly Total Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $329 |
| 2024-03-31 | $318 |
| 2023-12-31 | $343 |
| 2023-09-30 | $276 |
| 2023-06-30 | $275 |
| 2023-03-31 | $273 |
| 2022-12-31 | $279 |
| 2022-09-30 | $281 |
| 2022-06-30 | $294 |
| 2022-03-31 | $292 |
| 2021-12-31 | $271 |
| 2021-09-30 | $263 |
| 2021-06-30 | $241 |
| 2021-03-31 | $409 |
| 2020-12-31 | $401 |
| 2020-09-30 | $399 |
| 2020-06-30 | $379 |
| 2020-03-31 | $245 |
| 2019-12-31 | $253 |
| 2019-09-30 | $250 |
| 2019-06-30 | $246 |
| 2019-03-31 | $244 |
| 2018-12-31 | $218 |
| 2018-09-30 | $207 |
| 2018-06-30 | $204 |
| 2018-03-31 | $202 |
| 2017-12-31 | $205 |
| 2017-09-30 | $194 |
| 2017-06-30 | $180 |
| 2017-03-31 | $175 |
| 2016-12-31 | $182 |
| 2016-09-30 | $172 |
| 2016-06-30 | $166 |
| 2016-03-31 | $46 |
| 2015-12-31 | $57 |
| 2015-09-30 | $43 |
| 2015-06-30 | $36 |
| 2015-03-31 | $33 |
| 2014-12-31 | $30 |
| 2014-09-30 | $9 |
| 2014-06-30 | $0 |
| 2014-03-31 | $0 |
| 2013-12-31 | |
| 2013-09-30 | $0 |
| 2012-12-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.193B | $0.425B |
| Nevro Corp. is a medical device company which engages in developing and commercializing a neuromodulation platform for the treatment of chronic pain, primarily in the leg. The company is known for developing and commercializing the Senza spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. Additionally, the company's HF10 therapy provides long-lasting relief from chronic back and leg pain. Nevro's flagship Senza SCS system has been consistently driving the top line. Since its commercial launch in the United States, the system raked in significant revenues. These apart, Senza is commercially available in Europe since 2010 and in Australia since 2011. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $233.526B | 27.99 |
| Intuitive Surgical (ISRG) | United States | $167.663B | 94.93 |
| Alcon (ALC) | Switzerland | $46.690B | 32.87 |
| IQVIA Holdings (IQV) | United States | $44.312B | 25.11 |
| Edwards Lifesciences (EW) | United States | $40.246B | 25.80 |
| IDEXX Laboratories (IDXX) | United States | $38.877B | 46.77 |
| DexCom (DXCM) | United States | $27.494B | 39.21 |
| STERIS (STE) | Ireland | $23.650B | 27.60 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.114B | 0.00 |
| Waters (WAT) | United States | $19.521B | 29.10 |
| Hologic (HOLX) | United States | $18.946B | 20.60 |
| Sysmex ADR (SSMXY) | Japan | $11.776B | 36.93 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.549B | 12.95 |
| Teleflex (TFX) | United States | $11.522B | 17.91 |
| Globus Medical (GMED) | United States | $9.477B | 26.51 |
| Penumbra (PEN) | United States | $7.914B | 82.15 |
| Glaukos (GKOS) | United States | $7.104B | 0.00 |
| Masimo (MASI) | United States | $5.933B | 31.77 |
| TransMedics (TMDX) | United States | $4.666B | 199.83 |
| Integer Holdings (ITGR) | United States | $4.326B | 25.29 |
| PROCEPT BioRobotics (PRCT) | United States | $3.978B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $2.776B | 0.00 |
| Inari Medical (NARI) | United States | $2.652B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.555B | 14.99 |
| Nihon Kohden (NHNKY) | Japan | $2.508B | 15.61 |
| Elekta AB (EKTAY) | Sweden | $2.413B | 19.66 |
| Veracyte (VCYT) | United States | $2.195B | 136.05 |
| RxSight (RXST) | United States | $1.959B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.435B | 6.54 |
| Silk Road Medical (SILK) | United States | $1.098B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.090B | 19.44 |
| OPKO Health (OPK) | United States | $1.088B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $1.054B | 0.00 |
| Artivion (AORT) | United States | $1.052B | 96.58 |
| Alphatec Holdings (ATEC) | United States | $0.901B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.742B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.638B | 16.11 |
| SiBone (SIBN) | United States | $0.632B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.620B | 0.00 |
| Paragon 28 (FNA) | United States | $0.610B | 0.00 |
| AxoGen (AXGN) | United States | $0.571B | 0.00 |
| IRadimed (IRMD) | United States | $0.569B | 30.75 |
| Pacific Biosciences Of California (PACB) | United States | $0.431B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.331B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.328B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.319B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.314B | 9.57 |
| AngioDynamics (ANGO) | United States | $0.289B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.269B | 0.00 |
| Inogen (INGN) | United States | $0.268B | 0.00 |
| NeuroPace (NPCE) | United States | $0.210B | 0.00 |
| Accuray (ARAY) | United States | $0.191B | 0.00 |
| CVRx (CVRX) | United States | $0.183B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.167B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.165B | 11.58 |
| Alpha Tau Medical (DRTS) | Israel | $0.159B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.138B | 0.00 |
| 908 Devices (MASS) | United States | $0.124B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.115B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.113B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.090B | 13.46 |
| Monogram Orthopaedics (MGRM) | United States | $0.079B | 0.00 |
| InspireMD (NSPR) | Israel | $0.070B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.069B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.065B | 0.00 |
| Envoy Medical (COCH) | United States | $0.061B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 0.00 |
| LENSAR (LNSR) | United States | $0.053B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.052B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.041B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.036B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.033B | 0.00 |
| ReWalk Robotics (LFWD) | United States | $0.027B | 0.00 |
| DarioHealth (DRIO) | United States | $0.025B | 0.00 |
| Spectral AI (MDAI) | United States | $0.024B | 0.00 |
| Neuronetics (STIM) | United States | $0.023B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.021B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.021B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.015B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.014B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.014B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.011B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |